Show
Sort by
-
- Journal Article
- A1
- open access
Beyond the usual suspects : RSV infection in patients with hematological malignancies compared to influenza and SARS‐COV‐2 : a report from the EPICOVIDEHA/EPIRESEHA registry
-
Serum H-ferritin-to-ferritin ratio as a biomarker of hemophagocytic lymphohistiocytosis in critically ill patients with hyperferritinemia
-
- Journal Article
- A1
- open access
Novel flow cytometric antibody panel and dedicated analysis algorithm for automated fully standardized minimal residual disease detection in chronic lymphocytic leukemia
-
- Journal Article
- A1
- open access
Respiratory viruses in patients with hematological malignancy in boreal autumn/winter 2023–2024 : EPICOVIDEHA-EPIFLUEHA report
-
Subcutaneous epcoritamab with R-CHOP in previously untreated high-risk diffuse large B-cell lymphoma, including double-hit/triple-hit lymphoma : updated results from EPCORE NHL-2
(2023) AMERICAN JOURNAL OF HEMATOLOGY. In American Journal of Hematology 98(Supplement 5). p.S50-S50 -
Glofitamab monotherapy induces high complete response rates in patients with heavily pretreated relapsed/ refractory mantle cell lymphoma
(2023) AMERICAN JOURNAL OF HEMATOLOGY. In American Journal of Hematology 98(Supplement 5). p.S52-S53 -
- Journal Article
- A1
- open access
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies : an EPICOVIDEHA survey report
-
PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols
-
Characterization of duvelisib in patients with refractory marginal zone lymphoma : data from the phase 2 DYNAMO trial
-
Effect of dose modifications on response to duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the DUO trial